Literature DB >> 8841256

Life-threatening neutropenia following methotrexate treatment of ectopic pregnancy: a report of two cases.

J D Isaacs1, R P McGehee, B D Cowan.   

Abstract

BACKGROUND: Medical treatment of ectopic pregnancy with methotrexate is an increasingly common alternative to surgical management. Initial reports of methotrexate therapy described a very low incidence of complications. We report our experience with two patients who developed profound toxicity following methotrexate treatment of ectopic pregnancy. CASE: The first patient received a single dose of methotrexate (50 mg/m2 intramuscularly) for a confirmed ectopic pregnancy. The second patient received three doses of methotrexate (1 mg/kg). Both patients developed life-threatening neutropenia and febrile morbidity requiring hospitalization and supportive care.
CONCLUSION: To our knowledge, this is the first description of significant morbidity secondary to bone marrow suppression following methotrexate treatment of ectopic pregnancy. Most patients with ectopic pregnancy who are treated with methotrexate can expect resolution of their symptoms and a low risk of mild complications. However, serious complications after this therapy are possible and may occur even with the single-dose regimen.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8841256     DOI: 10.1016/0029-7844(96)00252-9

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

Review 1.  Tubal ectopic pregnancy.

Authors:  Rajesh Varma; Janesh Gupta
Journal:  BMJ Clin Evid       Date:  2012-02-10

2.  Tubal ectopic pregnancy.

Authors:  Vinod Kumar; Janesh Gupta
Journal:  BMJ Clin Evid       Date:  2015-11-16

Review 3.  Tubal ectopic pregnancy.

Authors:  Rajesh Varma; Janesh Gupta
Journal:  BMJ Clin Evid       Date:  2009-04-20

4.  Life-threatening complications following multidose methotrexate for medical management of ectopic pregnancy.

Authors:  Papa Dasari; Haritha Sagili
Journal:  BMJ Case Rep       Date:  2012-08-24

5.  Methotrexate-induced pancytopenia in a patient with ectopic pregnancy.

Authors:  Shih-Chieh Shao; Yea-Huei Kao Yang; Po-Shien Chien; Edward Chia-Cheng Lai
Journal:  Arch Med Sci       Date:  2016-03-23       Impact factor: 3.318

6.  Pregnancy of unknown location.

Authors:  Pedro Paulo Pereira; Fábio Roberto Cabar; Úrsula Trovato Gomez; Rossana Pulcineli Vieira Francisco
Journal:  Clinics (Sao Paulo)       Date:  2019-10-14       Impact factor: 2.365

7.  Fertility outcome after treatment of unruptured ectopic pregnancy with two different methotrexate protocols.

Authors:  Afsar Tabatabaii Bafghi; Fatemah Zaretezerjani; Leila Sekhavat; Raziah Dehghani Firouzabadi; Zeynab Ramazankhani
Journal:  Int J Fertil Steril       Date:  2012-12-17

8.  Multidosing Intramuscular Administration of Methotrexate in Interstitial Pregnancy With Very High Levels of β-hCG: A Case Report and Review of the Literature.

Authors:  Valeria Conti; Giovanni Luciano; Giovanni Pecoraro; Roberto Iovieno; Amelia Filippelli; Maurizio Guida
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-10       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.